Active Forum Topics | Getting Started | Interviews | EMR Forum | Medical | Billings | Press & News | Voice Recognition | The Water Cooler

emrupdate.com

Sign in | Join | Help

News » All Tags » Press Releases » chemotherapy (RSS)

emrupdate.com

Unbiased independant EMR discussions.

Browse by Tags

News

Home
About

Syndication

Recent Posts

Tags

Archives

New Model May Help Predict Response to Chemotherapy for Colorectal Cancer

Mathematical model measures stress level needed to produce cell death. Model could eventually be applied in other cancers. PHILADELPHIA — Scientists may be able to better predict which patients with colorectal cancer will respond to chemotherapy...

Published Thu, Jan 01 2013 12:05 AM by AACR News

Filed under: Press Releases, Research, Cancer, Media Materials, AACR, American Association for Cancer Research, chemotherapy, Cancer Research, colorectal cancer, journal, predict, model, DR_MOMP, MOMP, Dr. Jochen J.M. Prehn, mitochondrial outer membrane permeabilization, BCL-2
Cognitive Problems May Be Present Before Chemotherapy in Women With Breast Cancer

“Chemo brain” may be an inaccurate descriptor of cognitive issues. Fatigue is a key contributor to cognitive problems. Interventions to reduce stress and fatigue may alleviate postchemotherapy neurocognitive problems. SAN ANTONIO — Women...

Published Fri, Dec 12 2012 8:30 AM by AACR News

Filed under: Press Releases, Research, Breast Cancer, Cancer, Media Materials, AACR, American Association for Cancer Research, chemotherapy, women, CTRC-AACR San Antonio Breast Cancer Symposium, CTRC, press conference, San Antonio Breast Cancer Symposium, SABCS, Baylor College of Medicine, fatigue, Dr. Bernadine Cimprich, chemo brain
Adjuvant Bevacizumab Did Not Improve Invasive Disease-free Survival in Triple-negative Breast Cancer

Safety profile was consistent with previous trials of bevacizumab. More understanding of triple-negative breast cancer is still needed. Final overall survival data are expected in 2013. SAN ANTONIO — Patients who received one year of bevacizumab...

Published Fri, Dec 12 2012 8:30 AM by AACR News

Filed under: Press Releases, Research, Treatment, Breast Cancer, Cancer, Media Materials, AACR, American Association for Cancer Research, chemotherapy, CTRC-AACR San Antonio Breast Cancer Symposium, CTRC, triple-negative breast cancer, press conference, San Antonio Breast Cancer Symposium, SABCS, Baylor College of Medicine, bevacizumab, Dr. David Cameron, BEATRICE study
Minorities Most Likely to Have Aggressive Tumors, Less Likely to Get Radiation

Breast tumor aggressiveness increased receipt of chemotherapy, decreased adjuvant radiation utilization. Adjuvant radiation still under-recommended. Receiving chemotherapy decreased likelihood of radiation. SAN DIEGO — Women with aggressive breast...

Published Sun, Oct 10 2012 7:15 PM by AACR News

Filed under: Press Releases, Research, Breast Cancer, Conference, Cancer, Media Materials, AACR, American Association for Cancer Research, chemotherapy, minorities, women, Disparities, cancer health disparities, The Science of Cancer Health Disparities, Radiation therapy, Susan G. Komen Cancer Disparities Research, Abigail Silva
Mechanisms of Acquired Chemoresistance in Ovarian Cancer Identified

Disease has high heterogeneity. First-line chemosensitivity associated with subsequent chemoresistance. Gene identified that may predict chemoresistance. PHILADELPHIA — The presence of multiple ovarian cancer genomes in an individual patient and...

Published Wed, Aug 08 2012 12:05 AM by AACR News

Filed under: Press Releases, Research, Cancer, Media Materials, AACR, American Association for Cancer Research, chemotherapy, Cancer Research, women, ovarian cancer, journal, gene, chemoresistance, LRP1B, Dr. David Bowtell
Novel Chemotherapy Agent Appears to be a Promising Pancreatic Cancer Treatment

BAY 86-9766 offers survival benefit in mouse model of pancreatic cancer. Treatment yields remarkable tumor regression rapidly. Therapy effective in mice with advanced tumors. LAKE TAHOE, Nev. — A novel chemotherapeutic agent, the highly selective...

Published Wed, Jun 06 2012 3:30 PM by AACR News

Filed under: Press Releases, Research, Treatment, Conference, Cancer, Media Materials, AACR, American Association for Cancer Research, chemotherapy, pancreatic cancer, preclinical studies, Pancreatic Cancer: Progress and Challenges, Dr. Nicole Teichmann
Immunotherapy and Chemotherapy Regimen May Prolong Survival in Advanced Cancers

Lower doses of IL-2 and 13-cis retinoic acid increased natural “killer” cells. Combination therapy might benefit patients with stage 4 cancers. Patients who received this combination had improved survival rates. CHICAGO — Maintenance...

Published Mon, Apr 04 2012 9:02 AM by AACR News

Filed under: Press Releases, Research, Cancer, Media Materials, AACR, American Association for Cancer Research, chemotherapy, meeting, 2012 Annual Meeting, Annual Meeting, immunotherapy, AACR Annual Meeting 2012, interleukin-2, Dr. Francesco Recchia, stage 4 cancer, 13-cis retinoic acid, IL-2, maintenance therapy
Marker of DNA Damage Could Predict Response to Platinum Chemotherapy

Assay could direct treatment options for triple-negative breast cancer. Accumulations of telomere AI predicted sensitivity to therapy. PHILADELPHIA — Scientists have uncovered a marker of DNA damage that could predict who will respond to platinum...

Published Thu, Mar 03 2012 12:51 PM by AACR News

Filed under: Press Releases, Research, Treatment, Breast Cancer, Cancer, Media Materials, AACR, American Association for Cancer Research, Cancer Discovery, chemotherapy, women, journal, triple-negative breast cancer, tAI, telomeric allelic imbalance, platinum chemotherapy, cisplatin, carboplatin, Dr. Andrea Richardson
Patients Treated with Sunitinib and Sorafenib Respond to Flu Vaccine

Tweet • Flu vaccine could be used to test immune response. • Patients presented with metastatic renal cell cancer. • Implications beyond quality of life and patient management. PHILADELPHIA — Patients treated with sunitinib and sorafenib responded...

Published Tue, Jun 06 2011 1:00 PM by AACR News

Filed under: Press Releases, Research, influenza, Cancer, Media Materials, AACR, American Association for Cancer Research, chemotherapy, Radboud University Nijmegen Medical Center, sorafenib, Keith Flaherty, flu vaccine, immune system, metastatic renal cell cancer, Clinical Cancer Research, sunitinib, The Netherlands, Carla van Herpen

©2011 emrupdate.com. All rights reserved. | Acceptable Use Policy | Proud to be supported by the following EMR Vendor Sponsors:

eClinicalWorks | DescriptMED | EMR Experts | Medical Office Online | NextGen | TSI Healthcare

Getting Started | Forums | Medical | Blogs | Interviews | Unique Visits

ISP Providers | Timezones | Contact Sales